Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients

Details for Australian Patent Application No. 2009289452 (hide)

Owner A&G Pharmaceutical, Inc.

Inventors Serrero, Ginette

Agent Mallesons

Pub. Number AU-A-2009289452

PCT Pub. Number WO2010/028373

Priority 61/094,726 05.09.08 US; 61/122,130 12.12.08 US

Filing date 8 September 2009

Wipo publication date 11 March 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 April 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Apr 2011

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/028373 Priority application(s): WO2010/028373

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289464-Chewable sustained release formulations

2009289450-Multi-linked endoscopic device with spherical distal assembly